News items Marijn de Bruin appointed professor of Behavioural medicine and Health psychology
20 July 2021

As of 1 March 2021, behavioural scientist Marijn de Bruin is appointed Professor of 'Behavioural medicine & Health psychology' at Radboud University/Radboud university medical center. His research focuses on health behaviour in public and curative care.

Marijn de Bruin studies interventions to support healthy behaviour. Health behaviours such as smoking, physical activity or medication use have a major impact on our life expectancy and health care costs. Marijn de Bruin's research focuses on increasing the usefulness and impact of behavioural knowledge. First, he designs and evaluates interventions to support healthy behaviour, often for patients with long-term conditions such as HIV, hepatitis C or heart failure.

The second part of his scientific research focuses on improving research methods so that we can learn more from research already done and make future research better and more relevant. Thirdly, he wants to investigate how evidence about (cost-) effective behavioural interventions can be translated more effectively into policy and practice. Combined, this research programme should have a positive effect on both science and society.

Research during the corona crisis

Since March 2020, Marijn de Bruin mainly focusses on research on the behaviour of society during the COVID-19 pandemic. He is co-founder of the RIVM Corona Behavioural Unit, within which he is a member of the core team and head of scientific research. He has been working for this unit for over a year. He regularly consults with various ministries and speaks in the media about our behaviour. The behavioural science research into the perceptions, behaviour and welfare of citizens during the coronal pandemic was financed by ZonMw, NWO and the Ministry of Health, Welfare and Sport.

Health scientist in Maastricht and Aberdeen

Marijn de Bruin (1977, Amsterdam) studied health sciences at Maastricht University. In 2009 he received his PhD, also from Maastricht, for research on medication use among HIV patients (title of thesis: 'Theory- and evidence-based interventions to enhance adherence among HIV-infected patients using highly active antiretroviral therapy'). He worked for five years as a university lecturer at Wageningen University and Research and the University of Amsterdam. In 2013, he became Professor and Head of Health Psychology at the University of Aberdeen (Scotland). From 2018-2020, he combined this position with a role as senior researcher at IQ Healthcare of Radboud university medical center, where he had received a Hypatia Fellowship intended to attract external research leaders.

More information

Pauline Dekhuijzen

wetenschaps- en persvoorlichter

neem contact op

Related news items

Rosella Hermens appointed professor of Person-centered oncological integrated care

7 April 2022

Rosella Hermens has been appointed Professor of Person-centered oncological integrated care at Radboud university medical center/Radboud University. She investigates how care for patients with cancer can become more person-centered and better organized, while the patient remains in control.

read more

Nine million euros grant for population study with home tests

22 February 2022

NWO, the Dutch Heart Foundation, the Dutch Kidney Foundation, the Dutch Diabetes Fund and private partners are working together on a large national study into the early detection of cardiovascular diseases, chronic kidney disease and type 2 diabetes using home tests.

read more

Most COVID-19 ICU survivors experience symptoms one year after ICU admission Publication in JAMA

25 January 2022

75% of the COVID-19 survivors who were treated in the Intensive Care Unit (ICU) experience physical, mental and/or cognitive problems one-year post ICU. This shows the large-scale MONITOR-IC study led by Radboudumc.

read more

1.4 million euro to reduce hospital admissions due to medication

7 January 2022

A team of sixteen Dutch hospitals received a grant of 1.4 million euros from ZonMw. They will investigate whether they can reduce medication related hospital readmissions.

read more

Research into treatment for bladder pain syndrome will now be reimbursed

4 August 2021

Bladder pain syndrome, also called interstitial cystitis, is a chronic benign condition of the urinary bladder

read more

Obesity increases risk of death in uterine cancer PhD defense of Hannah Donkers on 22 April

22 April 2021

Research by Hannah Donkers shows that obesity causes a worse survival rate in women with uterine cancer. In addition, it appears that lower socioeconomic class and anemia also contribute.

read more